Jeongkuk Seo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jeongkuk Seo has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Byong Duk Ye
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
3 shared publications - Chang Hwan Choi
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea
2 shared publications - Jeong-Sik Byeon
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
2 shared publications Sang Hyoung Park
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
2 shared publicationsSeung Wook Hong
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
2 shared publications- Suk-Kyun Yang
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 32 (4) , 471-473
Small-Intestinal Motility in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cause, Consequence, or Bystander?
Jeongkuk Seo. J Neurogastroenterol Motil 2026;32:471-3. https://doi.org/10.5056/jnm26263
- 30 October 2026
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 32 (4) , 471-473
Open AccessSmall-Intestinal Motility in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cause, Consequence, or Bystander?
Jeongkuk Seo. J Neurogastroenterol Motil 2026;32:471-3. https://doi.org/10.5056/jnm26263
- 22 October 2026
- Published by Elsevier in Gastroenterology
What Men Live By: Family Ties as a Bridge to Persistent Nonparticipants in Colorectal Cancer Screening
- 22 October 2026
- Published by Elsevier in Gastroenterology
What Men Live By: Family Ties as a Bridge to Persistent Nonparticipants in Colorectal Cancer Screening
- Open Access
- 15 September 2026
- Published by Elsevier in SSRN Electronic Journal
Forecasting the Epidemiology of Inflammatory Bowel Disease in Brazil: A Temporal Evolution from 2012 to 2035
Background & Aims: Brazil is undergoing a rapid epidemiologic transition in inflammatory bowel disease (IBD). We aimed to characterize the temporal evolution of IBD in Brazil from 2012 to 2025 and forecast its burden through 2035, positioning the country within a global four-stage model.Methods: This nationwide, population-based study utilized the DATASUS database via the TT Disease Explorer platform. We identified individuals with Crohn’s Disease (CD), Ulcerative Colitis (UC), and IBD-Unclassifiable (IBD-U) using validated ICD-10 codes from the public healthcare system. Temporal trends (Annual Average Percent Changes: AAPCs) and autoregressive integrated moving average (ARIMA) modeling was used to forecast incidence and prevalence.Results: A total of 337,539 IBD patients were identified. Between 2012 and 2025, IBD prevalence rose from 29·85 to 158·18 per 100,000 inhabitants and IBD incidence rose from 9·35 to 12·34 per 100,000 inhabitants. The UC:CD prevalence ratio increased from 1·53:1 to 2·1:1. Hotspots were concentrated in the South and Southeast regions. ARIMA models forecast that IBD prevalence will reach 264·4 per 100,000, while incidence is forecasted to rise to 22·72 per 100,000 by 2035.Conclusions: The incidence and prevalence in Brazil are rising significantly. By 2035, this escalating burden will necessitate a structural shift in the public healthcare systems toward longitudinal models of chronic care management.
- 15 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessForecasting the Epidemiology of Inflammatory Bowel Disease in Brazil: A Temporal Evolution from 2012 to 2035
Background & Aims: Brazil is undergoing a rapid epidemiologic transition in inflammatory bowel disease (IBD). We aimed to characterize the temporal evolution of IBD in Brazil from 2012 to 2025 and forecast its burden through 2035, positioning the country within a global four-stage model.Methods: This nationwide, population-based study utilized the DATASUS database via the TT Disease Explorer platform. We identified individuals with Crohn’s Disease (CD), Ulcerative Colitis (UC), and IBD-Unclassifiable (IBD-U) using validated ICD-10 codes from the public healthcare system. Temporal trends (Annual Average Percent Changes: AAPCs) and autoregressive integrated moving average (ARIMA) modeling was used to forecast incidence and prevalence.Results: A total of 337,539 IBD patients were identified. Between 2012 and 2025, IBD prevalence rose from 29·85 to 158·18 per 100,000 inhabitants and IBD incidence rose from 9·35 to 12·34 per 100,000 inhabitants. The UC:CD prevalence ratio increased from 1·53:1 to 2·1:1. Hotspots were concentrated in the South and Southeast regions. ARIMA models forecast that IBD prevalence will reach 264·4 per 100,000, while incidence is forecasted to rise to 22·72 per 100,000 by 2035.Conclusions: The incidence and prevalence in Brazil are rising significantly. By 2035, this escalating burden will necessitate a structural shift in the public healthcare systems toward longitudinal models of chronic care management.
- Open Access
- 25 June 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (4) , 575-586
Age-Related Microbial Differences in Newly Diagnosed Crohn’s Disease Reveal the Distinct Enrichment of Oral-Associated Taxa in Pediatric Patients
Crohn's disease (CD) presents differently by age of onset, but the microbial distinctions between pediatric and adult CD are currently unclear. In this study, the gut microbiota of fecal samples collected from newly diagnosed patients with CD (n=88; pediatric 44, adult 44) and their age- and sex-matched healthy controls (HCs, n=112) was analyzed using 16S rRNA gene amplicon sequencing. Differential abundance analysis was performed using MaAsLin2 to identify age-specific microbial signatures, and enterotypes were classified using Dirichlet multinomial mixture modeling. Both pediatric and adult patients with CD exhibited shared dysbiosis characterized by reduced alpha diversity (pEnterobacteriaceae and Enterococcaceae, and depletion of short-chain fatty acid-producing taxa within Ruminococcaceae and Lachnospiraceae. Notably, enterotyping revealed that individuals with CD converged toward a shared, pathobiont-dominated enterotype regardless of age, overriding the age-dependent stratification observed in HCs. Despite this shared convergence, differences in age-stratified comparisons were observed. Adult CD patients exhibited enrichment of resident pathobionts such as Ruminococcus gnavus and Clostridium innocuum, whereas pediatric CD patients exhibited unique and pronounced enrichment of Pasteurellaceae, Neisseriaceae, and Gemellaceae (false discovery rate <0.1). In newly diagnosed patients, CD is characterized by shared dysbiosis and convergence toward a disease-specific enterotype across age groups. However, this was accompanied by distinct microbial features, specifically, the enrichment of taxa previously reported as prevalent in the oral microbiome in children versus resident pathobionts in adults. These findings suggest that age at disease onset is associated with age-stratified differences in microbial profiles in CD.
- 25 June 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (4) , 575-586
Open AccessAge-Related Microbial Differences in Newly Diagnosed Crohn’s Disease Reveal the Distinct Enrichment of Oral-Associated Taxa in Pediatric Patients
Crohn's disease (CD) presents differently by age of onset, but the microbial distinctions between pediatric and adult CD are currently unclear. In this study, the gut microbiota of fecal samples collected from newly diagnosed patients with CD (n=88; pediatric 44, adult 44) and their age- and sex-matched healthy controls (HCs, n=112) was analyzed using 16S rRNA gene amplicon sequencing. Differential abundance analysis was performed using MaAsLin2 to identify age-specific microbial signatures, and enterotypes were classified using Dirichlet multinomial mixture modeling. Both pediatric and adult patients with CD exhibited shared dysbiosis characterized by reduced alpha diversity (pEnterobacteriaceae and Enterococcaceae, and depletion of short-chain fatty acid-producing taxa within Ruminococcaceae and Lachnospiraceae. Notably, enterotyping revealed that individuals with CD converged toward a shared, pathobiont-dominated enterotype regardless of age, overriding the age-dependent stratification observed in HCs. Despite this shared convergence, differences in age-stratified comparisons were observed. Adult CD patients exhibited enrichment of resident pathobionts such as Ruminococcus gnavus and Clostridium innocuum, whereas pediatric CD patients exhibited unique and pronounced enrichment of Pasteurellaceae, Neisseriaceae, and Gemellaceae (false discovery rate <0.1). In newly diagnosed patients, CD is characterized by shared dysbiosis and convergence toward a disease-specific enterotype across age groups. However, this was accompanied by distinct microbial features, specifically, the enrichment of taxa previously reported as prevalent in the oral microbiome in children versus resident pathobionts in adults. These findings suggest that age at disease onset is associated with age-stratified differences in microbial profiles in CD.
- Open Access
- 20 December 2025
- Published by Korean Society of Gastrointestinal Cancer Research in Journal of Digestive Cancer Research
- Vol. 13 (3) , 224-227
The Use of Artificial Intelligence in Colorectal Cancer Risk Prediction Models: A Review
Jeongkuk Seo. Journal of Digestive Cancer Research 2025;13:224-7. https://doi.org/10.52927/jdcr.2025.13.3.224
- 20 December 2025
- Published by Korean Society of Gastrointestinal Cancer Research in Journal of Digestive Cancer Research
- Vol. 13 (3) , 224-227
Open AccessThe Use of Artificial Intelligence in Colorectal Cancer Risk Prediction Models: A Review
Jeongkuk Seo. Journal of Digestive Cancer Research 2025;13:224-7. https://doi.org/10.52927/jdcr.2025.13.3.224
- Open Access
- 30 July 2025
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 31 (3) , 293-295
From Morphology to Motion: Cine-magnetic Resonance Imaging in the Functional Assessment of Pseudo-obstruction
- 30 July 2025
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 31 (3) , 293-295
Open AccessFrom Morphology to Motion: Cine-magnetic Resonance Imaging in the Functional Assessment of Pseudo-obstruction
- 25 July 2025
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (10) , 1927-1937
Multiomics insights into functional constipation: Exploring microbiome, metabolome, and lipidome independent of transit time
- 25 July 2025
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (10) , 1927-1937
Multiomics insights into functional constipation: Exploring microbiome, metabolome, and lipidome independent of transit time
- Open Access
- 30 April 2025
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 31 (2) , 276-284
Validation of the London Classification for Rectal Hyposensitivity in an Anorectal Manometry Database of 2540 Patients With Functional Defecatory Disorder
Jeongkuk Seo, Kee Wook Jung, Sehee Kim, Seung Wook Hong, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, and Suk-Kyun Yang. J Neurogastroenterol Motil 2025;31:276-84. https://doi.org/10.5056/jnm24019
- 30 April 2025
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 31 (2) , 276-284
Open AccessValidation of the London Classification for Rectal Hyposensitivity in an Anorectal Manometry Database of 2540 Patients With Functional Defecatory Disorder
Jeongkuk Seo, Kee Wook Jung, Sehee Kim, Seung Wook Hong, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, and Suk-Kyun Yang. J Neurogastroenterol Motil 2025;31:276-84. https://doi.org/10.5056/jnm24019
- 17 October 2024
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 60 (11-12) , 1615-1616
Editorial: To Stop or Not to Stop, Is It Still a Question? Authors' Reply
- 17 October 2024
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 60 (11-12) , 1615-1616
Editorial: To Stop or Not to Stop, Is It Still a Question? Authors' Reply
- Open Access
- 4 August 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Comparing the Performance of ChatGPT, GPT-4, and Bard in the Korean Medical Licensing Examination: A Gastroenterology Perspective (Preprint)
BACKGROUND Artificial intelligence (AI) and deep learning are revolutionizing the field of medicine, including gastroenterology. Notable among these advancements are large language models (LLMs) like ChatGPT and Bard. While their effectiveness in the United States Medical Licensing Examination has been evaluated, their performance in non-English tests, such as the Korean Medical Licensing Examination (KMLE), remains underexplored. OBJECTIVE This study examined the performance of LLMs in the KMLE and assessed the explanation quality for gastroenterology questions. METHODS We analyzed the performance of three LLMs, ChatGPT (GPT-3.5), GPT-4, and Bard in the official KMLE questions from 2021 and 2022 by focusing on their accuracy and consistency. The questions were categorized based on their subject and the inclusion of images. The quality of explanations provided by the LLMs for gastroenterology questions was assessed using the Global Quality Score (GQS). RESULTS In KMLE 2021 and 2022, GPT-4 achieved accuracy rates of 72.1% and 62.5%, respectively, with consistency of approximately 60%. These rates were significantly higher than those of ChatGPT and Bard. The higher accuracy was maintained across most subjects, as well as in questions with images. For gastroenterology questions, GPT-4 achieved accuracy rates of 55.8% and 63.9% in KMLE 2021 and 2022, respectively. The GQS of GPT-4 was significantly higher than those of other models, even in cases of incorrect responses. CONCLUSIONS Unlike ChatGPT and Bard, GPT-4 achieved passing grades for the KMLE 2021 and 2022, and demonstrated high-quality explanations in gastroenterology. Further research on multimodal models and the use of prompt engineering is warranted.
- 4 August 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessComparing the Performance of ChatGPT, GPT-4, and Bard in the Korean Medical Licensing Examination: A Gastroenterology Perspective (Preprint)
BACKGROUND Artificial intelligence (AI) and deep learning are revolutionizing the field of medicine, including gastroenterology. Notable among these advancements are large language models (LLMs) like ChatGPT and Bard. While their effectiveness in the United States Medical Licensing Examination has been evaluated, their performance in non-English tests, such as the Korean Medical Licensing Examination (KMLE), remains underexplored. OBJECTIVE This study examined the performance of LLMs in the KMLE and assessed the explanation quality for gastroenterology questions. METHODS We analyzed the performance of three LLMs, ChatGPT (GPT-3.5), GPT-4, and Bard in the official KMLE questions from 2021 and 2022 by focusing on their accuracy and consistency. The questions were categorized based on their subject and the inclusion of images. The quality of explanations provided by the LLMs for gastroenterology questions was assessed using the Global Quality Score (GQS). RESULTS In KMLE 2021 and 2022, GPT-4 achieved accuracy rates of 72.1% and 62.5%, respectively, with consistency of approximately 60%. These rates were significantly higher than those of ChatGPT and Bard. The higher accuracy was maintained across most subjects, as well as in questions with images. For gastroenterology questions, GPT-4 achieved accuracy rates of 55.8% and 63.9% in KMLE 2021 and 2022, respectively. The GQS of GPT-4 was significantly higher than those of other models, even in cases of incorrect responses. CONCLUSIONS Unlike ChatGPT and Bard, GPT-4 achieved passing grades for the KMLE 2021 and 2022, and demonstrated high-quality explanations in gastroenterology. Further research on multimodal models and the use of prompt engineering is warranted.